ENTPD1 and malignant colon neoplasm: Entpd1-deficient mice that were administered B16-F10 mouse melanoma cells and MC-38 mouse colon cancer cells via the hepatic portal vein (experimental metastasis assay) were found to develop significantly fewer hepatic metastases than wildtype (control) mice (Sun et al. 2010).